News

Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...
We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...
The EU Court found the head of the European Commission, Ursula von der Leyen, responsible for concealing information about ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Patients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...
European Commission President Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission ...